Gene Symbol | C5AR1 |
Entrez ID | 728 |
Uniprot ID | P21730 |
Description | complement component 5a receptor 1 |
Chromosomal Location | chr19: 47,290,023-47,322,066 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000187 |
activation of MAPK activity |
The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
TAS |
BP |
GO:0006915 |
apoptotic process |
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
IEA |
BP |
GO:0006935 |
chemotaxis |
The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
TAS |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
IBA |
BP |
GO:0006955 |
immune response |
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
TAS |
BP |
GO:0006968 |
cellular defense response |
A defense response that is mediated by cells. |
TAS |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway |
The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
IBA |
BP |
GO:0007202 |
activation of phospholipase C activity |
The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand. |
TAS |
BP |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration |
Any process that increases the concentration of calcium ions in the cytosol. |
IEA |
BP |
GO:0007606 |
sensory perception of chemical stimulus |
The series of events required for an organism to receive a sensory chemical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process. |
TAS |
BP |
GO:0010575 |
positive regulation of vascular endothelial growth factor production |
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor. |
IEA |
BP |
GO:0010759 |
positive regulation of macrophage chemotaxis |
Any process that increases the rate, frequency or extent of macrophage chemotaxis. Macrophage chemotaxis is the movement of a macrophage in response to an external stimulus. |
IEA |
BP |
GO:0021534 |
cell proliferation in hindbrain |
The multiplication or reproduction of cells, resulting in the expansion of a cell population in the hindbrain. |
IEA |
BP |
GO:0030449 |
regulation of complement activation |
Any process that modulates the frequency, rate or extent of complement activation. |
TAS |
BP |
GO:0030593 |
neutrophil chemotaxis |
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
IEA |
BP |
GO:0031100 |
animal organ regeneration |
The regrowth of a lost or destroyed animal organ. |
IEA |
BP |
GO:0032494 |
response to peptidoglycan |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule. |
IEA |
BP |
GO:0032496 |
response to lipopolysaccharide |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IEA |
BP |
GO:0038178 |
complement component C5a signaling pathway |
A series of molecular signals generated as a consequence of a the C5a component of the complement pathway binding to a complement receptor, and ending with regulation of a downstream cellular process. C5a is a peptide derived from the C5 complement factor. |
IEA |
BP |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter |
The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. |
IDA |
BP |
GO:0043524 |
negative regulation of neuron apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. |
IEA |
BP |
GO:0045766 |
positive regulation of angiogenesis |
Any process that activates or increases angiogenesis. |
IEA |
BP |
GO:0050679 |
positive regulation of epithelial cell proliferation |
Any process that activates or increases the rate or extent of epithelial cell proliferation. |
IDA |
BP |
GO:0050830 |
defense response to Gram-positive bacterium |
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
IEA |
BP |
GO:0050900 |
leukocyte migration |
The movement of a leukocyte within or between different tissues and organs of the body. |
IBA |
BP |
GO:0060326 |
cell chemotaxis |
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
IBA |
BP |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IDA |
BP |
GO:0090023 |
positive regulation of neutrophil chemotaxis |
Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
TAS |
CC |
GO:0009986 |
cell surface |
The external part of the cell wall and/or plasma membrane. |
IEA |
CC |
GO:0016023 |
cytoplasmic, membrane-bounded vesicle |
A membrane-bounded vesicle found in the cytoplasm of the cell. |
IEA |
CC |
GO:0016323 |
basolateral plasma membrane |
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
IDA |
CC |
GO:0045177 |
apical part of cell |
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue. |
IDA |
MF |
GO:0001856 |
complement component C5a binding |
Interacting selectively and non-covalently with the C5a product of the complement cascade. |
IEA |
MF |
GO:0004878 |
complement component C5a receptor activity |
Combining with the C5a product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
IDA |
MF |
GO:0004930 |
G-protein coupled receptor activity |
Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
IEA |
Domain ID | Description |
---|---|
IPR000276 |
G protein-coupled receptor, rhodopsin-like |
IPR000826 |
Formyl peptide receptor-related |
IPR001274 |
C5a1/C5a2 anaphylatoxin chemotactic receptor |
IPR002234 |
Anaphylatoxin chemotactic receptor family |
IPR017452 |
GPCR, rhodopsin-like, 7TM |
IPR034320 |
C5a anaphylatoxin chemotactic receptor 1 |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04610 |
Complement and coagulation cascades |
KEGG |
hsa05150 |
Staphylococcus aureus infection |
KEGG |
WP3941 |
Oxidative Damage |
WikiPathways |
WP558 |
Complement and Coagulation Cascades |
WikiPathways |
WP24 |
Peptide GPCRs |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0017661 |
Iga Glomerulonephritis |
C0036983 |
Septic Shock |
Tissue | Cell Type |
---|---|
bone marrow |
hematopoietic cells |
spleen |
cells in red pulp |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15308691 |
Jansen et al. |
2004 |
Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
GNAI3 |
2773 |
P08754 |
0.55 |
ARRB1 |
408 |
P49407 |
0.65 |
ARRB2 |
409 |
P32121 |
0.65 |
C5AR1 |
728 |
P21730 |
0.66 |
RPS19 |
6223 |
P39019 |
0.62 |
SLC25A3 |
5250 |
Q00325 |
0.63 |
C5AR2 |
27202 |
Q9P296 |
0.65 |
WAS |
7454 |
P42768 |
0.67 |
GNAI2 |
2771 |
P04899 |
0.71 |
C5 |
727 |
P01031 |
0.75 |